ABL Named Small Business Champion by Montgomery County

ABL Named Small Business Champion by Montgomery County

  • July 10, 2015

Rockville, MD – July 10, 2015 – Thank you to Montgomery County Department of Economic Development for recognizing ABL as a Small Business Champion for the work we do to support our local small business community. Montgomery County Small Business Awards were announced June 24 at the Bethesda North Marriott Hotel and Conference Center at the annual event that celebrates and honors local small businesses.

As a company that has continued to grow with a wide range of services for over 50 years through both our government contracts and industry partners, we are very pleased to receive this award for our efforts to subcontract work to small, specialized firms in our area. Watch ABL’s CEO, Dr. Tom VanCott, talk about this award:

Montgomery County Executive Ike Leggett, along with Montgomery County Council President George Leventhal, Department of Economic Development Acting Director Sally Sternbach, Deputy Secretary of the Maryland Department of Business and Economic Development Benjamin Wu and District Director, U.S. Small Business Administration, Washington Metropolitan Area Office, Antonio Doss presented the awards and congratulated the recipients.

About ABL, Inc.

ABL, Inc. is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics and other biologic products. ABL has extensive experience working with diverse organizations, including the U.S. Government, biopharmaceutical companies and academic entities. Notable contract manufacturing services include process and assay development, cGMP biologics manufacturing of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC analytics in the U.S. and Europe. ABL also maintains U.S. and European immunological and molecular laboratories to support preclinical and GCLP clinical sample processing and testing. ABL is a part of the Institut Mérieux, a group of companies dedicated to developing translational science for better patient care globally.

For more information visit www.ablinc.com or email us.